3 FTSE 100 dividend stocks I’d buy to get a 5% cash income for life

Investing in these dividend stocks could drastically reduce the amount of money you need to provide a retirement income, says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

What’s the best way to generate a cash income? With best-buy cash ISA interest rates hovering around 1%, you’d need a pot of £2m to generate an annual income of around £20k. To generate the same income from a portfolio of dividend stocks yielding 5%, you’d only need £400k.

Of course, dividends aren’t guaranteed, as this year’s events have shown. But many companies have maintained their payouts or have already restarted dividend payments. Today I want to look at three FTSE 100 dividend stocks I’d buy for a regular income.

Long-term growth from healthcare

There aren’t many certainties in the world. But I think we can be sure that demand for modern healthcare will continue to grow for the foreseeable future. My main healthcare investment is GlaxoSmithKline (LSE: GSK), the FTSE 100 pharmaceutical and consumer health group.

Glaxo is a popular dividend stock, but in recent years performance has been held back by the declining sales of former blockbusters that have lost patent protection. One big example of this is asthma medicine Advair. More recently, vaccine sales have fallen as the Covid-19 pandemic has restricted non-emergency healthcare activity.

However, I expect the headwinds from the pandemic will soon start to reverse. Looking further ahead, GSK has a number of new products that should support medium-term growth. I also expect the planned separation of the group’s consumer business (which owns brands such as Sensodyne) to improve performance.

At current levels, Glaxo stock offers a dividend yield of 5.2%. I see this as a good level to buy for long-term investors.

A family-focused dividend stock

FTSE 100 asset manager Schroders (LSE: SDR) (LSE: SDRC) — which manages more than $500bn of investor assets — might not seem like a family firm. But Schroders’ founding family still has a controlling stake in this 216-year old firm.

I think this family ownership is reflected in the conservative, long-term strategy employed by the group.

For income investors, investing in family firms can make sense. The firm’s controlling shareholders won’t want to lose what might be their main source of income. In my experience, dividends paid by family firms are often more affordable and sustainable than at comparable firms with no long-term ownership.

I see Schroders as one of the best dividend stocks in the FTSE 100. The shareholder payout hasn’t been cut for more than 30 years. And if you buy the non-voting Schroders (LSE: SDRC) class of shares today, you can look forward to a 5.4% dividend yield.

A sinful 8% dividend yield

Tobacco stocks divide opinion like few others. But the reality is that in financial terms, selling cigarettes is still a very large and profitable business. As I write, FTSE 100 stock British American Tobacco (LSE: BATS) offers a well-supported dividend yield of 8.5%.

There are very few other companies that can offer such strong cash flows for shareholder returns. But tobacco stocks are out of favour at the moment. That’s left BATS trading on a modest valuation of around eight times earnings.

Owning this dividend stock isn’t without risk. Regulations on tobacco sales could change in the future. The decline in smoking rates could accelerate. And BATS’ large debt pile could cause problems for the firm.

However, I suspect that industry leaders like this one will be able to manage these problems and continue to reward shareholders. I rate the stock as a dividend buy.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares of British American Tobacco and GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline and Schroders (Non-Voting). Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

US Stock

The Nvidia share price falls! Here’s what I think happens next for the S&P 500

Jon Smith reviews the overnight results from Nvidia and explains why this could stall the S&P 500 performance through to…

Read more »

Investing Articles

Down 15% today, is this FTSE 100 share too cheap for me to miss?

JD Sports' share price has tanked after the FTSE 100 share released another profit warning. Is this the opportunity I've…

Read more »

Investing Articles

Up 8% today, is this FTSE 100 growth stock a slam-dunk buy for me?

Halma's share price is soaring thanks to another headline-grabbing trading update. Is the FTSE 100 stock now too good for…

Read more »

Investing Articles

With a P/E ratio of just 10.5 is now a brilliant time to buy a cut-price FTSE 250 tracker?

Harvey Jones says a recent dip in the FTSE 250 leaves the index trading at bargain levels. One stock in…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

To build a passive income flow, I’d follow this Warren Buffett approach

Warren Buffett has set up passive income streams most people can only dream about. Our writer sees some practical lessons…

Read more »

Growth Shares

As the boohoo share price falls, could it become a penny stock in 2025?

Jon Smith outlines some of the recent problems involving the boohoo share price and considers if things could get even…

Read more »

Young Asian woman with head in hands at her desk
Investing Articles

Here are the worst-performing FTSE 100 shares over the last 5 years

These five FTSE 100 shares have been complete duds over the last half decade. But is there potential for a…

Read more »

Investing Articles

Nvidia stock has tripled this year! Can it keep rising?

Nvidia's latest sales update showed strong growth and the stock's been on a tear so far in 2024. So is…

Read more »